Compositions and methods for treating thyroid disease
AssigneeScript Essentials, LLC
InventorSuzy Cohen
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of administering a compound for treating a patient suffering from thyroid disease and various thyroid-related disorders, including hyperthyroid and hypothyroid. The composition is preferably comprised of at least selenium, zinc, iodine, manganese, molybdenum, ashwaganda root powder, polygonum root extract, a digestive enzyme such as DPP-IV, L-tyrosine and mullein leaf, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule or tablet.
Claims17
A method for treating a thyroid disease comprising:
- administering an effective amount of a composition to a patient suffering from the thyroid disease, wherein the composition comprises:
- 1.5 to 3.5 mg of B6;
- 50 to 100 mcg of B12;
- 500 to 700 mcg of iodine;
- 50 to 150 mcg of selenium;
- 4 to 12 mg of zinc;
- 0.5 to 2 mg of manganese;
- 25 to 125 mcg to molybdenum;
- 450 to 600 mg of ashwaganda root powder;
- 102 to 170 mg of an extract selected from the group consisting of polygonum root extract, a grape seed extract, or combinations thereof;
- and
- 100 to 300 mg of at least one digestive enzyme.
A method for treating a thyroid disease by administering to a patient in need thereof a composition, wherein the composition comprises:
- 2 mg of B6;
- 90 mcg of B12;
- 500 mcg of iodine;
- 150 mcg of selenium;
- 10 mg of zinc;
- 2 mg of manganese;
- 75 mcg of molybdenum;
- 450 mg of ashwagandha root powder;
- 102 mg of polygonum root extract;
- 200 mg of DPP-IV;
- 75 mg of L-Tyrosine;
- 50 mg of mullein leaf;
- and
- wherein the composition is administered in the form of a single capsule.
Dependencies are inferred from the claim text.